Article citationsMore>>

Molina-Salinas, G.M., Pena-Rodriguez, L.M., Mata-Cardenas, B.D., Escalante-Erosa, F., Gonzalez-Hernandez, S., et al. (2011) Flourensia cernua: Hexane Extracts a Very Active Mycobactericidal Fraction from an Inactive Leaf Decoction against Pansensitive and Panresistant Mycobacterium tuberculosis. Evidence-Based Complementary and Alternative Medicine: eCAM, 2011, Article ID: 782503.

has been cited by the following article:

• TITLE: Natural Remedies against Multi-Drug Resistant Mycobacterium tuberculosis

  AUTHORS: Ramesh Pandit, Pawan Kumar Singh, Vipin Kumar

  KEYWORDS: Drug Resistant, Mycobacterium tuberculosis, Medicinal Plants, MDR or XDR-TB

  JOURNAL NAME: Journal of Tuberculosis Research, Vol.3 No.4, December 22, 2015

  ABSTRACT: Tuberculosis (TB), caused by Mycobacterium tuberculosis is an infectious deadly disease and the treatment of which is one of the most severe challenges at the global level. Currently more than 20 chemical medications are described for the treatment of TB. Regardless of availability of several drugs to treat TB, the causative agent, M. tuberculosis is nowadays getting resistant toward the conventional drugs and leading to conditions known as Multidrug-resistant tuberculosis (MDR-TB) and extensively drug resistant tuberculosis (XDR-TB). This situation has terrified the global health community and raised a demand for new anti-tuberculosis drugs. Medicinal plants have been used to cure different common as well as lethal diseases by ancient civilizations due to its virtue of variety of chemical compounds which may have some important remedial properties. The aim of the present review is to focus the anti-tubercular medicinal plants native to India as well as the plants effective against MDR or XDR-TB across the globe. In the present review, we have addressed 25 medicinal plants for TB and 16 plants effective against MDR-TB testified from India and 23 herbal plants described for MDR-TB across the world during 2011-2015. These herbal plants can serve as promising candidates for developing novel medications to combat multidrug resistant M. tuberculosis.